RYAN STEWART: Open Payments
NPI 1649207606 · SYRACUSE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 66 payments from 21 companies in 2025. Trend: 2023 $986 · 2024 $1,088 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $325 |
| GlaxoSmithKline, LLC. | 7 | $112 |
| Lilly USA, LLC | 8 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Verity Pharmaceuticals Inc. | 1 | $78 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| PFIZER INC. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Abbott Laboratories | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: UBRELVY, JARDIANCE, QULIPTA, VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, Tlando, NURTEC ODT.
Industry payments across UT — which companies pay providers there.
